Context Therapeutics
CNTX
#10592
Rank
A$48.31 M
Marketcap
A$0.53
Share price
1.77%
Change (1 day)
-64.93%
Change (1 year)

Earnings for Context Therapeutics (CNTX)

Earnings in 2026 (TTM): -A$60.08 Million

According to Context Therapeutics's latest financial reports the company's current earnings are N/A. In 2025 the company made an earning of -A$50.72 Million a decrease over its 2024 earnings that were of -A$37.52 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Context Therapeutics from 2020 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -A$60.08 Million18.46%
2025 -A$50.72 Million35.17%
2024 -A$37.52 Million11.52%
2023 -A$33.65 Million61.53%
2022 -A$20.83 Million41.88%
2021 -A$14.68 Million-257.38%
2020 A$9.32 M